Laura E. Strong

3.2k total citations · 2 hit papers
37 papers, 2.6k citations indexed

About

Laura E. Strong is a scholar working on Molecular Biology, Organic Chemistry and Biomaterials. According to data from OpenAlex, Laura E. Strong has authored 37 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Biomaterials. Recurrent topics in Laura E. Strong's work include Nanoparticle-Based Drug Delivery (6 papers), Chemical Synthesis and Analysis (6 papers) and Click Chemistry and Applications (5 papers). Laura E. Strong is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Chemical Synthesis and Analysis (6 papers) and Click Chemistry and Applications (5 papers). Laura E. Strong collaborates with scholars based in United States, United Kingdom and Netherlands. Laura E. Strong's co-authors include Laura L. Kiessling, Jason E. Gestwicki, Christopher W. Cairo, Karolyn A. Oetjen, Jennifer L. West, Eva J. Gordon, Nicholas A. Peppas, Jennifer M. Knipe, Xin Hu and David D. Manning and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Laura E. Strong

36 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic Multivalent Ligands as Probes of Signal Transduction

2006 724 citations Laura L. Kiessling, Jason E. Gestwicki et al. Angewandte Chemie International Edition profile →
Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture

2002 606 citations Jason E. Gestwicki, Christopher W. Cairo et al. Journal of the American Chemical Society profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura E. Strong United States	18	1.7k	1.1k	490	380	320	37	2.6k
Anouk Dirksen Netherlands	22	1.6k 0.9×	1.3k 1.2×	313 0.6×	545 1.4×	263 0.8×	34	2.7k
Macarena Sánchez‐Navarro Spain	24	1.3k 0.7×	596 0.5×	455 0.9×	223 0.6×	229 0.7×	50	2.1k
Élisabeth Garanger France	31	1.1k 0.7×	660 0.6×	1.2k 2.5×	301 0.8×	777 2.4×	76	2.8k
Samy Cecioni France	24	1.5k 0.9×	1.1k 0.9×	164 0.3×	320 0.8×	152 0.5×	33	2.0k
Jean‐Philippe Pellois United States	35	2.3k 1.3×	572 0.5×	364 0.7×	242 0.6×	584 1.8×	67	3.4k
Jun Guo China	26	1.9k 1.1×	2.1k 1.9×	247 0.5×	781 2.1×	276 0.9×	100	3.7k
Kathlynn C. Brown United States	29	1.4k 0.8×	509 0.5×	397 0.8×	627 1.6×	530 1.7×	58	2.6k
Raghavendra Kikkeri India	24	1.1k 0.6×	486 0.4×	280 0.6×	139 0.4×	287 0.9×	79	1.8k
Stanislav I. Presolski Singapore	14	1.6k 0.9×	2.0k 1.8×	230 0.5×	514 1.4×	335 1.0×	22	3.1k
Jessica R. Kramer United States	20	1.1k 0.6×	943 0.8×	597 1.2×	90 0.2×	138 0.4×	34	1.8k

Countries citing papers authored by Laura E. Strong

Since Specialization

Citations

This map shows the geographic impact of Laura E. Strong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Strong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Strong more than expected).

Fields of papers citing papers by Laura E. Strong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Strong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Strong. The network helps show where Laura E. Strong may publish in the future.

Co-authorship network of co-authors of Laura E. Strong

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Strong. A scholar is included among the top collaborators of Laura E. Strong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Strong. Laura E. Strong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coté, Gregory M., Michael Cecchini, Moh’d Khushman, et al.. (2025). 2688MO A phase I/II trial of FOG-001, a first-in-class direct β-catenin:TCF4 inhibitor - Safety and preliminary antitumor activity in patients with desmoid tumors. Annals of Oncology. 36. S1339–S1340.

Zhou, Xiaofei, Boris Grinshpun, Adekemi Taylor, et al.. (2025). Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR ‐1, ‐2, and ‐3, in Patients with Refractory Metastatic Colorectal Cancer. The Journal of Clinical Pharmacology. 65(7). 873–884. 2 indexed citations

Silverstein, William K., Jonathan S. Zipursky, Jerome A. Leis, et al.. (2023). Effect of Ward-Based High-Flow Nasal Cannula (HFNC) Oxygen Therapy on Critical Care Utilization During the COVID-19 Pandemic: A Retrospective Cohort Analysis. Journal of General Internal Medicine. 38(5). 1160–1166. 5 indexed citations

Strong, Laura E., et al.. (2021). Usability of an At-Home Anterior Nares SARS-CoV-2 RT-PCR Sample Collection Kit: Human Factors Feasibility Study. JMIR Human Factors. 8(4). e29234–e29234. 1 indexed citations

Strong, Laura E., et al.. (2014). Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery. Journal of Controlled Release. 178. 63–68. 72 indexed citations

Rutkoski, Thomas J., John A. Kink, Laura E. Strong, & Ronald T. Raines. (2013). Human Ribonuclease with a Pendant Poly(Ethylene Glycol) Inhibits Tumor Growth in Mice. Translational Oncology. 6(4). 392–397. 7 indexed citations

Strong, Laura E., John A. Kink, Baigen Mei, Mark N. Shahan, & Ronald T. Raines. (2012). First-in-human phase I clinical trial of QBI-139, a human ribonuclease variant, in solid tumors.. Journal of Clinical Oncology. 30(15_suppl). TPS3113–TPS3113. 11 indexed citations

Strong, Laura E. & Jennifer L. West. (2011). Thermally responsive polymer–nanoparticle composites for biomedical applications. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 3(3). 307–317. 80 indexed citations

Tripoliti, Elina, Laura E. Strong, Thomas Foltynie, et al.. (2011). Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease. Movement Disorders. 26(13). 2434–2436. 28 indexed citations

10.

Rutkoski, Thomas J., John A. Kink, Laura E. Strong, & Ronald T. Raines. (2011). Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity. Cancer Biology & Therapy. 12(3). 208–214. 12 indexed citations

11.

Kiessling, Laura L., Jason E. Gestwicki, & Laura E. Strong. (2006). Synthetic Multivalent Ligands as Probes of Signal Transduction. Angewandte Chemie International Edition. 45(15). 2348–2368. 724 indexed citations breakdown →

12.

Kiessling, Laura L., Jason E. Gestwicki, & Laura E. Strong. (2006). Synthetische multivalente Liganden als Sonden für die Signaltransduktion. Angewandte Chemie. 118(15). 2408–2429. 124 indexed citations

13.

Kiessling, Laura L., Jason E. Gestwicki, & Laura E. Strong. (2006). Synthetic Multivalent Ligands as Probes of Signal Transduction. ChemInform. 37(27). 7 indexed citations

14.

Gestwicki, Jason E., Laura E. Strong, Christopher W. Cairo, Frederick J. Boehm, & Laura L. Kiessling. (2002). Cell Aggregation by Scaffolded Receptor Clusters. Chemistry & Biology. 9(2). 163–169. 69 indexed citations

15.

Gestwicki, Jason E., Christopher W. Cairo, Laura E. Strong, Karolyn A. Oetjen, & Laura L. Kiessling. (2002). Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture. Journal of the American Chemical Society. 124(50). 14922–14933. 606 indexed citations breakdown →

16.

Lamanna, A, et al.. (2002). Conserved Amplification of Chemotactic Responses through Chemoreceptor Interactions. Journal of Bacteriology. 184(18). 4981–4987. 17 indexed citations

17.

Gestwicki, Jason E., Laura E. Strong, & Laura L. Kiessling. (2000). Tuning chemotactic responses with synthetic multivalent ligands. Chemistry & Biology. 7(8). 583–591. 74 indexed citations

18.

Gordon, Eva J., Jason E. Gestwicki, Laura E. Strong, & Laura L. Kiessling. (2000). Synthesis of end-labeled multivalent ligands for exploring cell-surface-receptor–ligand interactions. Chemistry & Biology. 7(1). 9–16. 114 indexed citations

19.

Strong, Laura E. & Laura L. Kiessling. (1999). A General Synthetic Route to Defined, Biologically Active Multivalent Arrays. Journal of the American Chemical Society. 121(26). 6193–6196. 175 indexed citations

20.

Gordon, Eva J., Laura E. Strong, & Laura L. Kiessling. (1998). Glycoprotein-inspired materials promote the proteolytic release of cell surface l-Selectin. Bioorganic & Medicinal Chemistry. 6(8). 1293–1299. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact